| Primary |
| Product Used For Unknown Indication |
15.3% |
| Arthritis |
14.1% |
| Osteoarthritis |
13.9% |
| Pain |
13.4% |
| Arthralgia |
5.6% |
| Rheumatoid Arthritis |
5.5% |
| Back Pain |
3.7% |
| Drug Use For Unknown Indication |
3.4% |
| Hypertension |
3.1% |
| Procedural Pain |
2.9% |
| Analgesic Therapy |
2.5% |
| Intervertebral Disc Protrusion |
2.3% |
| Pain In Extremity |
2.2% |
| Juvenile Arthritis |
1.9% |
| Multiple Myeloma |
1.9% |
| Musculoskeletal Pain |
1.9% |
| Antiplatelet Therapy |
1.8% |
| Depression |
1.6% |
| Tendonitis |
1.6% |
| Gout |
1.5% |
|
| Vomiting |
14.1% |
| Drug Ineffective |
7.3% |
| Rectal Haemorrhage |
6.3% |
| Therapeutic Response Unexpected With Drug Substitution |
6.3% |
| Completed Suicide |
5.8% |
| Gastrointestinal Haemorrhage |
5.8% |
| Myocardial Infarction |
5.8% |
| Weight Increased |
4.9% |
| Pain |
4.4% |
| Tinnitus |
4.4% |
| Product Substitution Issue |
3.9% |
| Renal Impairment |
3.9% |
| Dizziness |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Duodenal Ulcer |
3.4% |
| Haemorrhage |
3.4% |
| Renal Failure Acute |
3.4% |
| Swelling Face |
3.4% |
| Urticaria |
3.4% |
| Weight Decreased |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
26.2% |
| Drug Use For Unknown Indication |
13.0% |
| Osteoarthritis |
12.0% |
| Pain |
8.5% |
| Hypertension |
5.9% |
| Headache |
5.1% |
| Rheumatoid Arthritis |
4.8% |
| Fibromyalgia |
2.6% |
| Arthritis |
2.4% |
| Bone Disorder |
2.3% |
| Back Pain |
2.3% |
| Respiratory Disorder |
2.3% |
| Arthralgia |
2.0% |
| Depression |
1.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Blood Pressure Increased |
1.5% |
| Diabetes Mellitus |
1.5% |
| Constipation |
1.4% |
| Blood Cholesterol Increased |
1.3% |
| Pain In Extremity |
1.3% |
|
| Completed Suicide |
13.0% |
| Transient Ischaemic Attack |
9.3% |
| Squamous Cell Carcinoma |
7.0% |
| Fibromyalgia |
6.6% |
| Toxicity To Various Agents |
6.6% |
| Drug Ineffective |
6.0% |
| Vomiting |
6.0% |
| Rectal Haemorrhage |
5.6% |
| White Blood Cell Count Decreased |
4.7% |
| Coronary Artery Disease |
4.0% |
| Pain |
4.0% |
| Death |
3.7% |
| Drug Hypersensitivity |
3.3% |
| Renal Impairment |
3.3% |
| Somnolence |
3.0% |
| Vestibular Disorder |
3.0% |
| Weight Decreased |
3.0% |
| Atrial Fibrillation |
2.7% |
| Hyperkalaemia |
2.7% |
| Weight Increased |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Rheumatoid Arthritis |
19.2% |
| Drug Use For Unknown Indication |
14.4% |
| Pain |
6.1% |
| Hypertension |
5.4% |
| Arthritis |
2.7% |
| Depression |
2.6% |
| Psoriatic Arthropathy |
2.4% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Osteoporosis |
1.9% |
| Diabetes Mellitus |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Prophylaxis |
1.5% |
| Anxiety |
1.5% |
| Fibromyalgia |
1.4% |
| Insomnia |
1.3% |
| Ankylosing Spondylitis |
1.2% |
| Back Pain |
1.2% |
| Arthralgia |
1.2% |
| Asthma |
1.2% |
|
| Vomiting |
9.0% |
| Weight Decreased |
7.9% |
| Injection Site Pain |
6.8% |
| Weight Increased |
6.6% |
| Pain |
6.6% |
| Drug Ineffective |
6.5% |
| Urinary Tract Infection |
6.0% |
| Pain In Extremity |
5.2% |
| Nausea |
4.9% |
| Pyrexia |
4.4% |
| Pulmonary Embolism |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Pneumonia |
3.9% |
| Pruritus |
3.8% |
| Wrong Technique In Drug Usage Process |
3.8% |
| Rash |
3.8% |
| Sinusitis |
3.5% |
| Flushing |
3.3% |
| Tremor |
3.1% |
| Dyspnoea |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
10.2% |
| Pain |
10.2% |
| Cardiac Arrest |
8.0% |
| Myocardial Infarction |
8.0% |
| Blood Pressure |
6.8% |
| Blood Pressure Increased |
6.8% |
| Intervertebral Disc Protrusion |
6.8% |
| Psoriatic Arthropathy |
6.8% |
| Pleurisy |
5.7% |
| Contraception |
4.5% |
| Arthropathy |
3.4% |
| Embolism |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Anxiety |
2.3% |
| Gastric Disorder |
2.3% |
| Hypertension |
2.3% |
| Pleuritic Pain |
2.3% |
| Pulmonary Embolism |
2.3% |
| Sleep Disorder |
2.3% |
| Smoking Cessation Therapy |
2.3% |
|
| Haemorrhage |
11.1% |
| Pregnancy On Oral Contraceptive |
11.1% |
| Urine Colour Abnormal |
11.1% |
| Delirium |
7.4% |
| Respiratory Distress |
7.4% |
| Urticaria |
7.4% |
| Weight Decreased |
7.4% |
| Diarrhoea |
3.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Drug Interaction |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Metrorrhagia |
3.7% |
| Oropharyngeal Pain |
3.7% |
| Pulmonary Embolism |
3.7% |
| Scrotal Oedema |
3.7% |
| Somnolence |
3.7% |
| Weight Increased |
3.7% |
|
